Follow
Matthew Schwede
Matthew Schwede
Hematologist
Verified email at swedish.org
Title
Cited by
Cited by
Year
Taxonomy of breast cancer based on normal cell phenotype predicts outcome
S Santagata, A Thakkar, A Ergonul, B Wang, T Woo, R Hu, JC Harrell, ...
The Journal of clinical investigation 124 (2), 859-870, 2014
2312014
Profiles of genomic instability in high-grade serous ovarian cancer predict treatment outcome
ZC Wang, NJ Birkbak, AC Culhane, R Drapkin, A Fatima, R Tian, ...
Clinical cancer research 18 (20), 5806-5815, 2012
1732012
Genes for endosomal NHE6 and NHE9 are misregulated in autism brains
M Schwede, K Garbett, K Mirnics, DH Geschwind, EM Morrow
Molecular psychiatry 19 (3), 277-279, 2014
722014
Strong correlation of downregulated genes related to synaptic transmission and mitochondria in post-mortem autism cerebral cortex
M Schwede, S Nagpal, MJ Gandal, NN Parikshak, K Mirnics, ...
Journal of neurodevelopmental disorders 10, 1-9, 2018
572018
Mutations in mitochondrial enzyme GPT2 cause metabolic dysfunction and neurological disease with developmental and progressive features
Q Ouyang, T Nakayama, O Baytas, SM Davidson, C Yang, M Schmidt, ...
Proceedings of the National Academy of Sciences 113 (38), E5598-E5607, 2016
542016
Gene expression signature of normal cell-of-origin predicts ovarian tumor outcomes
MA Merritt, S Bentink, M Schwede, MP Iwanicki, J Quackenbush, T Woo, ...
PloS one 8 (11), e80314, 2013
512013
Stem cell-like gene expression in ovarian cancer predicts type II subtype and prognosis
M Schwede, D Spentzos, S Bentink, O Hofmann, B Haibe-Kains, ...
PloS one 8 (3), e57799, 2013
492013
Compliance and falsification of duty hours: reports from residents and program directors
BC Drolet, M Schwede, KD Bishop, SA Fischer
Journal of graduate medical education 5 (3), 368-373, 2013
442013
Expansion of the clinical phenotype associated with mutations in activity-dependent neuroprotective protein
MF Pescosolido, M Schwede, AJ Harrison, M Schmidt, ED Gamsiz, ...
Journal of medical genetics 51 (9), 587-589, 2014
392014
The impact of stroma admixture on molecular subtypes and prognostic gene signatures in serous ovarian cancer
M Schwede, L Waldron, SC Mok, W Wei, A Basunia, MA Merritt, ...
Cancer Epidemiology, Biomarkers & Prevention 29 (2), 509-519, 2020
382020
Therapeutic implications of GIPC1 silencing in cancer
TW Chittenden, J Pak, R Rubio, H Cheng, K Holton, N Prendergast, ...
PloS one 5 (12), e15581, 2010
342010
An unbalanced translocation involving loss of 10q26. 2 and gain of 11q25 in a pedigree with autism spectrum disorder and cerebellar juvenile pilocytic astrocytoma
HM Minhas, MF Pescosolido, M Schwede, J Piasecka, J Gaitanis, ...
American Journal of Medical Genetics Part A 161 (4), 787-791, 2013
312013
Clinician recognition of the acute respiratory distress syndrome: risk factors for under-recognition and trends over time
M Schwede, RY Lee, H Zhuo, KN Kangelaris, A Jauregui, K Vessel, ...
Critical care medicine 48 (6), 830-837, 2020
202020
Effects of bone marrow‐derived mesenchymal stromal cells on gene expression in human alveolar type II cells exposed to TNF‐α, IL‐1β, and IFN‐γ
M Schwede, EM Wilfong, RL Zemans, PJ Lee, C Dos Santos, X Fang, ...
Physiological Reports 6 (16), e13831, 2018
142018
Proinflammatory cytokines and ARDS pulmonary edema fluid induce CD40 on human mesenchymal stromal cells—A potential mechanism for immune modulation
EM Wilfong, R Croze, X Fang, M Schwede, E Niemi, GY Lopez, JW Lee, ...
Plos one 15 (10), e0240319, 2020
92020
Venetoclax monotherapy for cutaneous blastic plasmacytoid dendritic cell neoplasm
M Schwede, IT Tan, DF Atibalentja, MM Dickman, KE Rieger, GN Mannis
Annals of Hematology 99, 2973-2975, 2020
42020
Bone Marrow Derived Human Mesenchymal Stem Cells Exposed to Pro-Inflammatory Cytokines Lose their Mesenchymal Marker Expression and Transform into Cells with Antigen Presenting …
M Schwede, EM Wilfong, CS Calfee, M Matthay
B28. ADVANCES IN STEM CELLS IN INJURY AND REPAIR FOR 2016, A3075-A3075, 2016
22016
Preparing for Clerkships: Learning to Deliver Specialty-Specific Oral Presentations
M Daniel, RP Heney, B Kwan, C Mannino, C Williams, K McDonald, ...
MedEdPORTAL Publications 11, 10261, 2015
22015
Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity
M Schwede, K Jahn, J Kuipers, LA Miles, RL Bowman, T Robinson, ...
Leukemia, 1-10, 2024
12024
Development of Circulating Tumor DNA (ctDNA) for Molecular Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML)
R Gunaratne, C Zhou, JW Tai, M Schwede, K Tanaka, M Alkaitis, R Yin, ...
Blood 142, 4307, 2023
12023
The system can't perform the operation now. Try again later.
Articles 1–20